Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 8132

1.

In vitro modulation of tumor progression-associated properties of hormone refractory prostate carcinoma cell lines by cytokines.

Sokoloff MH, Tso CL, Kaboo R, Taneja S, Pang S, deKernion JB, Belldegrun AS.

Cancer. 1996 May 1;77(9):1862-72.

2.

In vitro modulation of the invasive and metastatic potentials of human renal cell carcinoma by interleukin-2 and/or interferon-alpha gene transfer.

Hathorn RW, Tso CL, Kaboo R, Pang S, Figlin R, Sawyers C, deKernion JB, Belldegrun A.

Cancer. 1994 Oct 1;74(7):1904-11.

3.

Suramin-induced decrease in prostate-specific antigen expression with no effect on tumor growth in the LNCaP model of human prostate cancer.

Thalmann GN, Sikes RA, Chang SM, Johnston DA, von Eschenbach AC, Chung LW.

J Natl Cancer Inst. 1996 Jun 19;88(12):794-801.

PMID:
8637045
4.
6.

Androgen deprivation induces selective outgrowth of aggressive hormone-refractory prostate cancer clones expressing distinct cellular and molecular properties not present in parental androgen-dependent cancer cells.

Tso CL, McBride WH, Sun J, Patel B, Tsui KH, Paik SH, Gitlitz B, Caliliw R, van Ophoven A, Wu L, deKernion J, Belldegrun A.

Cancer J. 2000 Jul-Aug;6(4):220-33.

PMID:
11038142
7.

Dissociation between androgen responsiveness for malignant growth vs. expression of prostate specific differentiation markers PSA, hK2, and PSMA in human prostate cancer models.

Denmeade SR, Sokoll LJ, Dalrymple S, Rosen DM, Gady AM, Bruzek D, Ricklis RM, Isaacs JT.

Prostate. 2003 Mar 1;54(4):249-57.

PMID:
12539223
8.
9.

Human renal carcinoma line transfected with interleukin-2 and/or interferon alpha gene(s): implications for live cancer vaccines.

Belldegrun A, Tso CL, Sakata T, Duckett T, Brunda MJ, Barsky SH, Chai J, Kaboo R, Lavey RS, McBride WH, et al.

J Natl Cancer Inst. 1993 Feb 3;85(3):207-16.

PMID:
8423625
10.

Expression of human prostatic acid phosphatase correlates with androgen-stimulated cell proliferation in prostate cancer cell lines.

Lin MF, Meng TC, Rao PS, Chang C, Schonthal AH, Lin FF.

J Biol Chem. 1998 Mar 6;273(10):5939-47.

11.
12.

Autocrine regulation of prostate-specific antigen gene expression in a human prostatic cancer (LNCaP) subline.

Hsieh JT, Wu HC, Gleave ME, von Eschenbach AC, Chung LW.

Cancer Res. 1993 Jun 15;53(12):2852-7.

13.

Effect of canarypox virus (ALVAC)-mediated cytokine expression on murine prostate tumor growth.

Kawakita M, Rao GS, Ritchey JK, Ornstein DK, Hudson MA, Tartaglia J, Paoletti E, Humphrey PA, Harmon TJ, Ratliff TL.

J Natl Cancer Inst. 1997 Mar 19;89(6):428-36.

PMID:
9091644
16.

Changes in endogenous cytokines, adhesion molecules and platelets during cytokine-induced tumour necrosis.

de Kossodo S, Moore R, Gschmeissner S, East N, Upton C, Balkwill FR.

Br J Cancer. 1995 Nov;72(5):1165-72.

17.

Piperazine-designed alpha 1A/alpha 1D-adrenoceptor blocker KMUP-1 and doxazosin provide down-regulation of androgen receptor and PSA in prostatic LNCaP cells growth and specifically in xenografts.

Liu CM, Lo YC, Tai MH, Wu BN, Wu WJ, Chou YH, Chai CY, Huang CH, Chen IJ.

Prostate. 2009 May 1;69(6):610-23. doi: 10.1002/pros.20919.

PMID:
19143029
19.

Down-regulation of neu/HER-2 by interferon-gamma in prostate cancer cells.

Kominsky SL, Hobeika AC, Lake FA, Torres BA, Johnson HM.

Cancer Res. 2000 Jul 15;60(14):3904-8.

20.

Androgen receptor protein is down-regulated by basic fibroblast growth factor in prostate cancer cells.

Cronauer MV, Nessler-Menardi C, Klocker H, Maly K, Hobisch A, Bartsch G, Culig Z.

Br J Cancer. 2000 Jan;82(1):39-45.

Supplemental Content

Support Center